Combined antiretroviral and anti-tuberculosis drug resistance following incarceration

被引：0
|
作者：
Stott, K. E. [1 ]
de Oliviera, T. [1 ,2 ]
Lessells, R. J. [1 ,3 ]
机构：
[1] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa
[2] UCL, Res Dept Infect, London, England
[3] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England
来源：
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE | 2013年 / 14卷 / 03期
基金：
英国惠康基金;
关键词：
SUB-SAHARAN AFRICA; SOUTH-AFRICA; HIV; TUBERCULOSIS; THERAPY; PRISON; INDIVIDUALS; INFECTION; MUTATIONS; CELL;
D O I：
10.7196/SAJHIVMED.957
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework
引用
收藏
页码：135 / 137
页数：3
相关论文
共 50 条
  • [41] Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey
    Kamal, S. M. M.
    Hossain, Md A.
    Sultana, S.
    Begum, V.
    Haque, N.
    Ahmed, Md J.
    Rahman, T. M. A.
    Hyder, Md K. A.
    Hossain, Md S.
    Rahman, M.
    Chowdhury, R. A.
    Aung, K. J. M.
    Islam, Md A.
    Hasan, Md R.
    Van Deun, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (02) : 151 - 156
  • [42] Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis
    Abbadi, Said H.
    Sameaa, G. Abdel
    Morlock, G.
    Cooksey, R. C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (06) : 673 - 678
  • [43] Anti-tuberculosis drug resistance patterns and trends in a tuberculosis referral hospital, 1997-2009
    Liu, C. H.
    Li, H. M.
    Li, L.
    Hu, Y. L.
    Wang, Q.
    Yang, N.
    Wang, S.
    Zhu, B.
    EPIDEMIOLOGY AND INFECTION, 2011, 139 (12) : 1909 - 1918
  • [44] Oxadiazole scaffolds in anti-tuberculosis drug discovery
    De, Suparna S.
    Khambete, Mihir P.
    Degani, Mariam S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 1999 - 2007
  • [45] Requirements for anti-tuberculosis drug tender requests
    Trébucq, A
    Caudron, JM
    Pinel, J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (11) : S358 - S361
  • [46] Development of New Anti-tuberculosis Drug Candidates
    Shi, Ruiru
    Sugawara, Isamu
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 221 (02) : 97 - 106
  • [47] World epidemiology of tuberculosis and resistance against anti-tuberculosis drugs
    Grosset, J
    Zunic, L
    Morcrette, C
    ANNALES DE MEDECINE INTERNE, 2002, 153 (02): : 107 - 112
  • [48] Resistance to anti-tuberculosis medications in the Horn of Africa
    Olle-Goig, J. E.
    Codina-Grau, G.
    Martin-Casabona, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (03) : 414 - 416
  • [49] Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua
    Chacon, L.
    Lainez, M.
    Rosales, E.
    Mercado, M.
    Caminero, J. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (01) : 62 - 67
  • [50] Anti-tuberculosis drug resistance in strains of Mycobacterium tuberculosis isolated from patients in a tertiary hospital in Bahia
    Matos, Eliana Dias
    Moreira Lemos, Antonio Carlos
    Bittencourt, Carolina
    Mesquita, Cristiane Leite
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03) : 331 - 338
12345